1
Indications / Contraindications
Indications
- Post-surgical anastomotic stricture: hepaticojejunostomy (Whipple, liver transplant), choledochojejunostomy, T-tube tract stricture
- PSC (primary sclerosing cholangitis) dominant stricture causing obstructive symptoms or cholangitis
- Chronic pancreatitis — CBD stricture from peri-ductal fibrosis
- Iatrogenic: post-cholecystectomy bile duct injury or stricture
- Ischemic: post-liver transplant hepatic artery thrombosis causing ischemic stricture
- When ERCP not feasible: surgically altered anatomy, papillary stenosis, biliary-enteric anastomosis
Contraindications
- Active uncontrolled cholangitis — treat with antibiotics and external drainage first
- Uncorrectable coagulopathy
- Unknown etiology — biopsy and confirm benign vs. malignant before benign protocol. Cholangiocarcinoma in a PSC patient is the classic pitfall.
Key Principle
Benign strictures require plastic stents or repeated balloon dilation + temporary plastic stent — NOT permanent SEMS. Metallic stents in benign disease cause chronic inflammation, become embedded, and severely complicate future surgical repair.
2
Pre-Procedure Checklist
MRCP (gold standard planning tool). Maps stricture anatomy, length, upstream dilation, downstream anatomy. Essential for anastomotic strictures with altered anatomy. Do not proceed without this imaging.
Confirm benign etiology. Brush cytology or biopsies at ERCP or percutaneous access. PSC vs. cholangiocarcinoma distinction is critical and non-negotiable before committing to a benign protocol.
Labs. LFTs (baseline bilirubin, ALP, GGT), coagulation panel (INR, platelets), blood cultures if febrile. Correct coagulopathy to INR <1.5, platelets >50K before procedure.
Antibiotics: required. 1 g ceftriaxone IV; continue 48–72h post-procedure. Benign strictures with chronic partial obstruction harbor biliary colonization.
Set expectations: this is a 6–18 month process. Discuss with the patient at the first visit that serial dilations are standard — typically 4–6 sessions over 12–18 months. Not a single-procedure cure.
Surgical consultation. Is definitive surgical repair (hepaticojejunostomy revision) the better option? IR is often the bridge or is used when surgery is high-risk or when anatomy precludes repair. Coordinate with HPB surgery and transplant team.
3
Relevant Anatomy
Anastomotic Stricture Locations
- Hepaticojejunostomy (HJ) anastomosis at liver hilum — post-Whipple, liver transplant biliary reconstruction
- Choledochojejunostomy (CJ) anastomosis at mid-CBD — typical of biliary bypass surgery
- Right or left hepatic duct stricture — from segmental injury or ischemia
- Post-liver transplant: biliary anastomosis at hepatic hilum — duct-to-duct or biliary-enteric reconstruction
PSC Anatomy
- Multiple intrahepatic duct strictures (beaded appearance on MRCP)
- Dominant stricture = significantly tighter than background PSC changes — target for percutaneous dilation
- Diffuse disease may not be amenable to percutaneous intervention — systemic disease process
- PSC patients are at high risk for cholangiocarcinoma — brush cytology at every access
Access Planning for Altered Anatomy
- Post-Whipple (hepaticojejunostomy): Roux limb occupies where duodenum was. Left hepatic approach is often preferred to reach the anastomosis at the hilum. The jejunal limb may be visible on MRCP as the target downstream structure.
- Post-transplant: biliary anastomosis may be at varying positions depending on surgical reconstruction. MRCP review with the transplant team before first access is strongly recommended.
- PSC: Target the dominant stricture identified on MRCP. Approach selection (left vs. right) depends on which duct provides the best angle to the dominant stricture.
4
Technique
Default RadCall approach · share your own below
Supplies
Established or new PTBD access
0.035" hydrophilic wire (Glidewire)
0.035" Amplatz stiff wire
Angled directional catheter (Cobra C2 or Berenstein)
Biliary balloon catheter (6–8 mm × 4 cm, high pressure)
7–10 Fr plastic biliary stent
Stent deployment pusher catheter
Dilute contrast + syringes
Fluoroscopy
Benign Stricture Protocol
- Day 1: 8.5–10.2 Fr internal-external biliary drain placement
- Day 2–3: Upsize to 12 Fr internal-external drain
- Week 3–4: Upsize to 14 Fr ± balloon cholangioplasty of stricture; consider retrievable WallFlex RX stent graft for 2–3 months if technically feasible, with internal-external drain placed through it for future access and to prevent stent migration
- Week 5–6: Upsize to 16 Fr ± balloon cholangioplasty of stricture
- Week 7–8: Upsize to 18 Fr ± balloon cholangioplasty of stricture
- Month 3: Upsize to 20 Fr or retrieve
- Month 6: Amplatz Anchor external catheter trial
- Month 6, Day 2: Antegrade cholangiogram through Anchor catheter + serum bilirubin and alkaline phosphatase. (A) If bile duct patent and chemistries acceptable, remove external drain. (B) If clinical or imaging signs of recurrent biliary obstruction, replace 14 Fr internal-external drain and discuss options with surgical team.
Steps (Balloon Dilation Visit)
1
Access
Establish or use existing PTBD access. Confirm biliary access fluoroscopically before advancing guidewire.
2
Cholangiogram
Delineate stricture anatomy. Measure stricture length. Note upstream biliary dilation caliber — this is your target for balloon size selection. Compare to prior cholangiogram if available.
3
Cross the stricture
Angled catheter (Cobra C2) + Glidewire through the stricture into the downstream duct or enteral limb. Patient positioning adjustment may help. Confirm wire is below stricture. HJ anastomosis: confirm wire tip is in the jejunal limb, not in a loop or pocket.
4
Balloon dilation
Advance the 6–8 mm biliary balloon over the wire across the stricture. Inflate to nominal pressure (8–12 atm). Hold 3–5 minutes — do not rush this. Deflate and re-inflate 2–3 times. Fluoroscopic endpoint: waist of balloon at stricture disappears with adequate dilation. Document fluoroscopic images of balloon deflation and re-inflation.
5
Post-dilation cholangiogram
Document improved caliber at the stricture. Note any extravasation: minor mucosal injury is acceptable; free spill of contrast into peritoneum = stop and drain. If significant extravasation: abort dilation, leave drain proximal, return in 3–4 weeks.
6
Place internal/external biliary stent
Advance the 7–10 Fr internal-external biliary stent across the stricture. Position all sideholes spanning the stricture with the stent holding the stricture open. Confirm on cholangiogram.
7
Maintain external limb
Keep the external drainage limb of the internal-external stent patent until stricture resolution is confirmed. This provides access for future exchanges and a safety valve for drainage failure.
Sign in to view and create community cards
5
Troubleshooting
Problem
Cannot cross the stricture (complete occlusion)
Likely cause: Fibrotic obliteration of the anastomosis or stricture. More common in late post-operative or post-ischemic strictures. Post-Whipple anastomoses that have fully scarred over present this way.
Next step: Try different catheter angulations and hydrophilic wire combinations. Consider rendezvous technique: combined ERCP (or EUS-directed) + percutaneous approach — ERCP tries from below while percutaneous accesses from above; meeting in the middle. If truly impassable: percutaneous dilation is not possible — surgical revision required. Place external drain for palliation while surgical planning proceeds.
Problem
Extravasation during balloon dilation
Likely cause: Balloon over-inflation, balloon positioned partially outside the duct, or fragile ischemic duct wall unable to tolerate dilation pressure.
Next step: Small amount of extravasation into surrounding tissue: acceptable — deflate balloon, leave drain, monitor patient. Free spill into peritoneum or significant biloma: stop dilation immediately. Leave large-bore drain in place proximal to the injury. Return in 3–4 weeks once healed — ischemic duct walls need more recovery time. Consider lower balloon pressure at next attempt.
Problem
Recurrent stricture after multiple dilations
Likely cause: Fibroblast overgrowth from ongoing ischemia (transplant), persistent inflammation (PSC), or insufficient dilation protocol duration.
Next step: If PSC dominant stricture: ensure cholangiocarcinoma has been excluded at each intervention (brush cytology). Consider referral for liver transplant evaluation — PSC is a liver transplant indication. Post-ischemic transplant stricture: poor response to dilation — discuss re-transplantation with transplant team. For anastomotic stricture: prolonged stenting protocol (up to 24 months) or surgical revision of the anastomosis.
Problem
PSC dominant stricture — cholangiocarcinoma concern
Likely cause: PSC patient presenting with a new dominant stricture or worsening obstruction. PSC carries 10–15% lifetime risk of cholangiocarcinoma.
Next step: Brush cytology is MANDATORY at every access in PSC patients. If cytology positive or suspicious: do NOT continue benign protocol. Oncology and HPB surgery referral. CA19-9 and CEA have poor sensitivity in PSC. Fluorescence in situ hybridization (FISH) cytology has better sensitivity for cholangiocarcinoma in PSC.
6
Complications
Procedure-Related
- Cholangitis / sepsis (most common) — prophylactic antibiotics critical; benign strictures are often chronically colonized
- Duct perforation / extravasation — from aggressive balloon dilation in ischemic or fragile duct; stop and drain if significant
- Hemobilia — hepatic artery injury during access; usually minor
- Pancreatitis — if stent placed near pancreatic duct orifice in distal CBD strictures
Long-Term
- Stricture recurrence (~30% at 5 years) — rule of thumb: 70% long-term success with protocol dilation for anastomotic strictures
- Plastic stent occlusion — q3 month exchange is mandatory; occlusion → cholangitis
- Progressive PSC — dilation is palliative; does not halt underlying disease progression
- Missed cholangiocarcinoma in PSC — the most catastrophic delayed complication; biopsy at every access
7
Post-Procedure & Multi-Visit Management
Visit Schedule
- Initial visit: Access + decompression (Stage 1)
- Week 1–2: Return for balloon dilation + stent placement (Stage 2)
- Q3 months thereafter: Stent exchange + balloon dilation × 3–4 sessions (Stage 3+)
- Total duration: Typically 12–18 months of stenting protocol
Endpoint Definition
- Stricture diameter ≥80% of normal duct caliber on cholangiogram
- LFTs normalized (bilirubin, ALP, GGT at baseline levels)
- Patient asymptomatic ≥6 months after stent removal
- Final cholangiogram confirms patent stricture without stent in place
Stent Removal Protocol
- When resolution criteria met: remove external limb of internal-external stent
- Remove plastic stent over wire through existing tract
- Final cholangiogram: confirm patent stricture site without stent
- Tract seals spontaneously after catheter removal in a well-matured tract
Failure Criteria → Surgical Referral
- No improvement after 3 dilation sessions
- Worsening stricture or recurrence after initial resolution
- Complete fibrotic obliteration preventing crossing
- Post-ischemic stricture with poor healing response
- PSC with recurrence requiring evaluation for transplant listing
8
Critical Pearls
✦
NEVER place permanent SEMS for benign disease. Metallic stents in benign biliary strictures cause chronic inflammation, become embedded in the duct wall, and severely complicate future surgical options. PSC patients who later need liver transplantation with embedded metallic stents in their biliary system face catastrophically difficult reoperations.
✦
Multiple sessions are expected — set this expectation on day one. Counsel the patient at the outset that this is a 6–18 month process involving 4–6 procedures. Managing expectations prevents patient frustration and abandonment of a successful protocol midway through.
✦
Balloon dilation duration matters. Hold the balloon inflated at nominal pressure for 3–5 minutes per inflation, not a quick inflate-deflate. Prolonged dilation fatigues the fibrotic tissue and achieves better long-term remodeling than rapid cycling.
✦
PSC dominant stricture + cytology: always. Brush or biopsy at every percutaneous access in a PSC patient without exception. PSC carries a 10–15% lifetime cholangiocarcinoma risk. The dominant stricture is cholangiocarcinoma until proven otherwise.
✦
Post-transplant ischemic stricture: worst responder. Hepatic artery thrombosis → ischemic bile duct → poor fibroblast repair → recurrence almost inevitable despite protocol dilation. Liver re-transplantation is often the only definitive option. Set realistic expectations early with the transplant team.
✦
Anastomotic strictures (Whipple, transplant) are best responders. Short-segment, well-defined anastomotic strictures with good underlying duct wall healing capacity have 70–80% long-term success with protocol dilation. This is where percutaneous management truly pays dividends.
✦
Rendezvous technique for impassable anastomosis. When the stricture cannot be crossed percutaneously, a combined approach with ERCP (passing a wire from below) and percutaneous from above can allow a through-and-through wire that makes dilation possible. Requires coordination with advanced endoscopy.
9
Benign Stricture Etiology & Prognosis
| Etiology | Typical Location | Dilation Success | Special Consideration |
|---|---|---|---|
| Post-cholecystectomy | Distal CHD | 70–80% | ERCP first-line; IR if ERCP fails or anatomy prevents |
| Post-Whipple HJ | HJ anastomosis (hilum) | 65–75% | Altered anatomy → percutaneous preferred over ERCP |
| Post-liver transplant duct-to-duct | Mid-CBD anastomosis | 70–85% (early); ~40% ischemic | Hepatic artery patency critical; ischemic = poor response |
| Post-transplant HJ | Hepatic hilum | 55–70% | Complex anatomy; may need bilateral approach |
| PSC dominant stricture | Hilum or intrahepatic | 50–60% symptom relief | Cholangiocarcinoma exclusion mandatory at every session |
| Chronic pancreatitis | Distal CBD | 50–60% | Consider surgical drainage (Frey/Puestow) for definitive management |
| Radiation stricture | Variable | 40–50% | Slow healing; multiple sessions; ischemic duct — handle gently |
Overall Protocol Summary
- Duration: 12–18 months total for a full dilation protocol
- Sessions: 4–6 balloon dilation + stent exchange visits at q3 month intervals
- Best outcomes: Anastomotic strictures in otherwise healthy biliary ducts with good blood supply
- Worst outcomes: Post-ischemic (hepatic artery thrombosis) — diffuse duct injury, poor healing capacity
- Multidisciplinary requirement: HPB surgery, transplant hepatology, and advanced endoscopy involvement improves outcomes
10
References & Resources
Primary sources · Key data · Related procedures
Key Guidelines
- ESGE guideline: Endoscopic management of benign biliary strictures (2022)
- SIR quality improvement guidelines for percutaneous biliary interventions
Primary References
- Familiari P, Bulajic M, Boskoski I, et al; ESGE. Clinical practice guideline: Endoscopic management of benign biliary strictures. Endoscopy. 2023;55(6):554–577.
- Saad WE, Wallace MJ, Wojak JC, Kundu S, Cardella JF. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol. 2010;21(6):789–795.
- Cantu P, Hookey LC, Morales A, Le Moine O, Devière J. The treatment of patients with symptomatic common bile duct stenosis secondary to chronic pancreatitis using partially covered metal stents. Endoscopy. 2005;37(8):735–739.